Collaborative research has led to a drug development startup that develops small-molecule therapies designed to promote regeneration and repair of multiple tissues. The therapies have the potential to address many serious disease conditions.
Date Time
Case Western Reserve awarded $3 million National Cancer Institute grant to apply AI to immunotherapy
Scientists, medical researchers at Case Western Reserve, NYU Langone Health and University Hospitals using machine-learning to predict response to immunotherapy
Medical researchers from Case Western Reserve University, New York University (NYU), and University Hospitals have been awarded a five-year, $3 million National Cancer Institute grant to develop and apply artificial intelligence (AI) tools for predicting which lung cancer patients will respond to immunotherapy.
A unique aspect of the Case Western Reserve-led study is that it will involve testing of their specific AI tools-for the first time during an ongoing clinical trial.